ArticleFrontiers in pharmacology2025

Continuous response to maintenance fuzuloparib for germline BRCA2- mutated metastatic pancreatic adenocarcinoma: a case report and literature review.

Chenyan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.